Rovadicitinib hydrochloride

Modify Date: 2024-04-05 20:22:48

Rovadicitinib hydrochloride structure	Common Name	Rovadicitinib hydrochloride
	CAS Number	1948242-60-1	Molecular Weight	357.84
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₇H₂₀ClN₇	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Rovadicitinib hydrochloride

Rovadicitinib hydrochloride is a JAK inhibitor with an IC50 value <20 nM. Rovadicitinib hydrochloride also exhibits anti-inflammatory activity[1][2].

Name	Rovadicitinib hydrochloride

Description	Rovadicitinib hydrochloride is a JAK inhibitor with an IC50 value <20 nM. Rovadicitinib hydrochloride also exhibits anti-inflammatory activity[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology
References	[1]. WHO Drug Informat ion - World Health Organization (WHO). [2]. Zhu Li, et al. Preparation of pyrrolopyrimidines as Janus kinase inhibitors: World Intellectual Property Organization, WO2016095805. 2016-06-23. [3]. WHO Drug Information-World Health Organization (WHO).

Description

Rovadicitinib hydrochloride is a JAK inhibitor with an IC50 value <20 nM. Rovadicitinib hydrochloride also exhibits anti-inflammatory activity[1][2].

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> JAK/STAT Signaling >> JAK

Signaling Pathways >> Epigenetics >> JAK

Signaling Pathways >> Stem Cell/Wnt >> JAK

Research Areas >> Inflammation/Immunology

References